Citation of paper, Subcutaneous trastuzumab (Herceptin) versus intravenous trastuzumab for the treatment of patients with HER2-positive breast cancer: A time, motion and cost assessment study in a lean operating day care oncology unit

Authors Citing This Paper

AuthorCiting PapersAuthor's PapersAuthor's CitationsAuthor's IF
Steven R A Simoens21203,0034.5
Jurandyr M Andrade1735,1177.5
James O Lindsay1714,04614.2
Geert D'Haens115616,70914.3
Ana C Santos1671,1795.7
Stefan Schreiber1604,3298.8
Ilaria Massa1352721.6
Roberta Maltoni1688792
Jong Hyuk Lee110673.3
J R Fraser Cummings1584,8248.7
Andrew M Wardley112014,45610.4
Arnold G Vulto1518724.9
Raquel Seiça11053,2413.9
Andrea Allmendinger1222983.2
Wolfgang F Richter1301,2726.1
Paul Emery164867,97110.1
10
Rita De Santis1591,9982.4
Joana A D Sequeira171617.1
Rene Westhovens11887,6986.8
Rieke E Alten11166,5975.9
Daniel Guimarães Tiezzi1572,3535.2
Dong Churl Suh1524381.5
Barbara DuMond1111
Mattia Altini1483252.1
Cyrielle Gilletta de Saint Joseph14102.3
Subrata Ghosh142923,5517.6
David J Reeves1384032
Antônio José Ribeiro1735,4577
George I'ons1110.5
Francisco Veiga12339,5384.8
Ella Evron191642.8
Antal Tamás Zemplenyi116961.3
Nicola Gentili113531.2
Ji Hoon Jeong12566,9454.5
Ben Parker1316499.9
Zoltan Kalo11242,1921.9
Silvio Danese159527,0048.1
Elena Nikiphorou11271,6333.6
Stefania Kokkali19271.2
HoUng Kim161,35134.4
Gerald Gartlehner11639,6156.9

Journals Citing This Paper